A detailed history of Gryphon Financial Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 29,004 shares of PFE stock, worth $774,986. This represents 0.11% of its overall portfolio holdings.

Number of Shares
29,004
Previous 21,098 37.47%
Holding current value
$774,986
Previous $590,000 42.2%
% of portfolio
0.11%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $218,996 - $248,169
7,906 Added 37.47%
29,004 $839,000
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $19,930 - $23,354
-789 Reduced 3.6%
21,098 $590,000
Q1 2024

May 01, 2024

SELL
$25.89 - $29.73 $130,873 - $150,285
-5,055 Reduced 18.76%
21,887 $607,000
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $214,109 - $278,104
8,194 Added 43.71%
26,942 $775,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $225,913 - $264,070
-7,040 Reduced 27.3%
18,748 $621,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $88,674 - $102,594
-2,455 Reduced 8.69%
25,788 $945,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $12,132 - $15,794
-308 Reduced 1.08%
28,243 $1.15 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $7,055 - $9,210
169 Added 0.6%
28,551 $1.46 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $111,456 - $136,060
-2,547 Reduced 8.23%
28,382 $1.24 Million
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $139 - $165
3 Added 0.01%
30,929 $1.62 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $386,587 - $479,030
-8,450 Reduced 21.46%
30,926 $1.6 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $555,877 - $823,996
13,453 Added 51.9%
39,376 $2.33 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $193,659 - $248,772
4,934 Added 23.51%
25,923 $1.12 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $18,278 - $20,706
509 Added 2.49%
20,989 $806,000
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $5,492 - $6,194
164 Added 0.81%
20,480 $742,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $13,890 - $17,662
415 Added 2.09%
20,316 $748,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $16,097 - $18,885
507 Added 2.61%
19,901 $731,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $3,252 - $3,946
-108 Reduced 0.55%
19,394 $634,000
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $30,111 - $43,022
-1,114 Reduced 5.4%
19,502 $637,000
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $24,657 - $27,982
-749 Reduced 3.51%
20,616 $807,000
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $40,027 - $51,904
1,232 Added 6.12%
21,365 $768,000
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $18,157 - $20,386
-491 Reduced 2.38%
20,133 $872,000
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $396,675 - $435,813
-10,578 Reduced 33.9%
20,624 $876,000
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $409,705 - $467,109
10,650 Added 51.82%
31,202 $1.28 Million
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $276,863 - $335,817
8,032 Added 64.15%
20,552 $906,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $6,035 - $6,434
-183 Reduced 1.44%
12,520 $454,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $49,588 - $57,529
1,554 Added 13.94%
12,703 $450,000
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $370,815 - $393,448
11,149
11,149 $404,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.